Advertisement
Canada markets close in 2 hours 25 minutes
  • S&P/TSX

    21,985.73
    +100.35 (+0.46%)
     
  • S&P 500

    5,113.37
    +64.95 (+1.29%)
     
  • DOW

    38,322.91
    +237.11 (+0.62%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    83.83
    +0.26 (+0.31%)
     
  • Bitcoin CAD

    87,270.16
    -893.73 (-1.01%)
     
  • CMC Crypto 200

    1,325.63
    -70.91 (-5.08%)
     
  • GOLD FUTURES

    2,348.10
    +5.60 (+0.24%)
     
  • RUSSELL 2000

    2,004.65
    +23.54 (+1.19%)
     
  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     
  • NASDAQ

    15,975.92
    +364.16 (+2.33%)
     
  • VOLATILITY

    15.06
    -0.31 (-2.02%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     

Today's Research Reports on Trending Tickers: Canopy Growth and AbbVie

NEW YORK, NY / ACCESSWIRE / June 18, 2018 / U.S. market plunged on Friday, but well-off session lows as investors appeared to look at previous signs of escalating trade tension between Washington and Beijing. The Dow Jones Industrial Average fell 0.34 percent to close at 25,090.48, while the S&P 500 Index declined 0.10 percent to close at 2,779.66. The Nasdaq Composite Index shed 0.19 percent to close at 7,746.38.

According to SlateStone Wealth chief investment strategist, Robert Pavlik, "People are worried that the trade issue could turn into something much more serious. It's obviously never good to think you could be entering a trade war with another major economy, and it brings a lot of uncertainty to the equation." "That being said, people are still hopeful that this is a lot of chest pounding and negotiation tactics, as opposed to something more lasting. The market could be in a position to give something back if this persists, but unless things really escalate, I don't think that will last," Pavlik added.

RDI Initiates Coverage on:

Canopy Growth Corporation
https://rdinvesting.com/news/?ticker=CGC

ADVERTISEMENT

AbbVie Inc.
https://rdinvesting.com/news/?ticker=ABBV

Canopy Growth's stock moved 1.29% higher Friday, to close the day at $29.87. The stock recorded a trading volume of 1,314,087 shares, which was above its three months average volume of 1,300,007 shares. In the last year, Canopy Growth's shares have traded in a range of 0.44 - 32.78. The share price has gained 6688.64% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $27.29 is above its 200-day moving average of $18.83. Shares of Canopy Growth have gained roughly 15.52 percent in the past month and are up 6,201.69 percent year-to-date.

Access RDI's Canopy Growth Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CGC

On Friday, shares of AbbVie recorded a trading volume of 20,806,241 shares, which was above the three months average volume of 9,189,195 shares. The stock ended the day 0.83% higher at $99.57. The share price has fallen 20.89% from its 52 week high with a 52 week trading range of 69.38 - 125.86. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $101.40 is below its 200-day moving average of $103.17. Shares of the company are trading at a Price to Earnings ratio of 25.04. Shares of AbbVie have fallen roughly 5.46 percent in the past month and are up 2.96 percent year-to-date.

Access RDI's AbbVie Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ABBV

Our Actionable Research on Canopy Growth Corporation (NYSE:CGC) and AbbVie Inc. (NYSE:ABBV) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com